Acorda Therapeutics, Inc. Purchase Obligation
Acorda Therapeutics, Inc. had Purchase Obligation of $100.59 million as of 2021-12-31, per its 10-K filed 2022-03-18.
Discontinued › Notes › Commitment and Contingencies › Purchase Obligation, Fiscal Year Maturity
us-gaap:PurchaseObligation · last filed 2022-03-18
- 2021-12-31: Purchase Obligation $100.59M.
- 2020-12-31: Purchase Obligation $2.76M.
- 2019-12-31: Purchase Obligation $2.80M.
- 2018-12-31: Purchase Obligation $2.28M.
| Period end | Purchase Obligation |
|---|---|
| 2021-12-31 | $100.59M 10-K · filed 2022-03-18 |
| 2020-12-31 | $2.76M 10-K · filed 2021-03-16 |
| 2019-12-31 | $2.80M 10-K · filed 2020-02-28 |
| 2018-12-31 | $2.28M 10-K · filed 2019-02-27 |
| 2017-12-31 | $16.08M 10-K/A · filed 2018-03-09 |
| 2016-12-31 | $30.79M 10-K · filed 2017-02-27 |
| 2016-09-30 | $34.98M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $30.48M 10-Q · filed 2016-08-04 |